122 related articles for article (PubMed ID: 17259635)
1. Identification of genes directly regulated by the oncogene ZNF217 using chromatin immunoprecipitation (ChIP)-chip assays.
Krig SR; Jin VX; Bieda MC; O'Geen H; Yaswen P; Green R; Farnham PJ
J Biol Chem; 2007 Mar; 282(13):9703-9712. PubMed ID: 17259635
[TBL] [Abstract][Full Text] [Related]
2. Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha.
Frietze S; O'Geen H; Littlepage LE; Simion C; Sweeney CA; Farnham PJ; Krig SR
BMC Genomics; 2014 Jun; 15(1):520. PubMed ID: 24962896
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression.
Littlepage LE; Adler AS; Kouros-Mehr H; Huang G; Chou J; Krig SR; Griffith OL; Korkola JE; Qu K; Lawson DA; Xue Q; Sternlicht MD; Dijkgraaf GJ; Yaswen P; Rugo HS; Sweeney CA; Collins CC; Gray JW; Chang HY; Werb Z
Cancer Discov; 2012 Jul; 2(7):638-51. PubMed ID: 22728437
[TBL] [Abstract][Full Text] [Related]
4. ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells.
Krig SR; Miller JK; Frietze S; Beckett LA; Neve RM; Farnham PJ; Yaswen PI; Sweeney CA
Oncogene; 2010 Oct; 29(40):5500-10. PubMed ID: 20661224
[TBL] [Abstract][Full Text] [Related]
5. Genome analysis identifies the p15ink4b tumor suppressor as a direct target of the ZNF217/CoREST complex.
Thillainadesan G; Isovic M; Loney E; Andrews J; Tini M; Torchia J
Mol Cell Biol; 2008 Oct; 28(19):6066-77. PubMed ID: 18625718
[TBL] [Abstract][Full Text] [Related]
6. ZNF217: An Oncogenic Transcription Factor and Potential Therapeutic Target for Multiple Human Cancers.
Wang Y; Ma C; Yang X; Gao J; Sun Z
Cancer Manag Res; 2024; 16():49-62. PubMed ID: 38259608
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl fumarate inhibits ZNF217 and can be beneficial in a subset of estrogen receptor positive breast cancers.
Sharma T; Zhang Y; Zigrossi A; Cravatt BF; Kastrati I
Breast Cancer Res Treat; 2023 Oct; 201(3):561-570. PubMed ID: 37477798
[TBL] [Abstract][Full Text] [Related]
8. The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor Progression.
Fahmé P; Ramadan F; Le DT; Thi KN; Ghayad SE; Hussein N; Diaz C; Croset M; Clézardin P; Cohen PA
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551531
[TBL] [Abstract][Full Text] [Related]
9. Effect of a Bone Morphogenetic Protein-2-derived peptide on the expression of tumor marker ZNF217 in osteoblasts and MCF-7 cells.
Mantsou A; Pitou M; Papachristou E; Papi RM; Lamprou P; Choli-Papadopoulou T
Bone Rep; 2021 Dec; 15():101125. PubMed ID: 34632002
[TBL] [Abstract][Full Text] [Related]
10. ZNF217: the cerberus who fails to guard the gateway to lethal malignancy.
Li Y; Wu H; Wang Q; Xu S
Am J Cancer Res; 2021; 11(7):3378-3405. PubMed ID: 34354851
[TBL] [Abstract][Full Text] [Related]
11. Function and Regulation of Nuclear DNA Sensors During Viral Infection and Tumorigenesis.
Zhang F; Yuan Y; Ma F
Front Immunol; 2020; 11():624556. PubMed ID: 33505405
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 Metabolism of Polyunsaturated Fatty Acids and Neurodegeneration.
Sarparast M; Dattmore D; Alan J; Lee KSS
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33207662
[TBL] [Abstract][Full Text] [Related]
13. SOX10-regulated promoter use defines isoform-specific gene expression in Schwann cells.
Fogarty EA; Kitzman JO; Antonellis A
BMC Genomics; 2020 Aug; 21(1):549. PubMed ID: 32770939
[TBL] [Abstract][Full Text] [Related]
14. ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma.
Wang T; Zhong H; Qin Y; Wei W; Li Z; Huang M; Luo X
Biomed Res Int; 2020; 2020():3575038. PubMed ID: 32685472
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibition boosts autophagic degradation of ubiquitinated-AGR2 and enhances the antitumor efficiency of bevacizumab.
Wang D; Xu Q; Yuan Q; Jia M; Niu H; Liu X; Zhang J; Young CY; Yuan H
Oncogene; 2019 May; 38(18):3458-3474. PubMed ID: 30647455
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress.
Jiang X; Zhang C; Qi S; Guo S; Chen Y; Du E; Zhang H; Wang X; Liu R; Qiao B; Yang K; Zhang Z; Xu Y
Oncotarget; 2016 Dec; 7(51):84893-84906. PubMed ID: 27768596
[TBL] [Abstract][Full Text] [Related]
17. ZNF217/ZFP217 Meets Chromatin and RNA.
Lee DF; Walsh MJ; Aguiló F
Trends Biochem Sci; 2016 Dec; 41(12):986-988. PubMed ID: 27519282
[TBL] [Abstract][Full Text] [Related]
18. Coordination of m(6)A mRNA Methylation and Gene Transcription by ZFP217 Regulates Pluripotency and Reprogramming.
Aguilo F; Zhang F; Sancho A; Fidalgo M; Di Cecilia S; Vashisht A; Lee DF; Chen CH; Rengasamy M; Andino B; Jahouh F; Roman A; Krig SR; Wang R; Zhang W; Wohlschlegel JA; Wang J; Walsh MJ
Cell Stem Cell; 2015 Dec; 17(6):689-704. PubMed ID: 26526723
[TBL] [Abstract][Full Text] [Related]
19. The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value.
Cohen PA; Donini CF; Nguyen NT; Lincet H; Vendrell JA
Oncotarget; 2015 Dec; 6(39):41566-81. PubMed ID: 26431164
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus transcription factor Zta acts through distal regulatory elements to directly control cellular gene expression.
Ramasubramanyan S; Osborn K; Al-Mohammad R; Naranjo Perez-Fernandez IB; Zuo J; Balan N; Godfrey A; Patel H; Peters G; Rowe M; Jenner RG; Sinclair AJ
Nucleic Acids Res; 2015 Apr; 43(7):3563-77. PubMed ID: 25779048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
